General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Cash Flows

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 6 Months Ended 7 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2018
Sep. 30, 2020
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
OPERATING ACTIVITIES:                        
Net loss             $ (158,400,000)   $ (119,100,000)   $ (122,000,000.0)  
Adjustments to reconcile net loss to net cash provided by operating activities:                        
Accrual of in-kind interest on notes payable to related parties             121,200,000   107,700,000   95,600,000  
Depreciation and amortization expense             83,600,000   68,400,000   69,500,000  
Share-based compensation expense               200,000   100,000  
Loss on debt extinguishment             0   0   12,800,000  
Amortization of debt issuance costs             3,200,000   2,600,000   3,600,000  
Provision for doubtful accounts             2,100,000   600,000   500,000  
Inventory obsolescence write down             700,000   1,900,000    
Change in deferred income taxes             (16,600,000)   (15,500,000)   (16,100,000)  
(Gain) loss on disposal of property, plant and equipment             (100,000)   400,000   1,200,000  
Loss (gain) on foreign currency transactions             13,400,000   (1,700,000)   2,700,000  
Other             1,400,000   (900,000)   (100,000)  
Changes in operating assets and liabilities:                        
Accounts receivable             (4,200,000)   3,800,000   10,600,000  
Costs in excess of billings on uncompleted contracts             (3,800,000)   (2,900,000)   (8,100,000)  
Inventories             1,000,000.0   4,300,000   (7,800,000)  
Deferred cost of revenue             6,600,000   (3,500,000)   (200,000)  
Prepaid expenses and other current assets             (10,100,000)   (1,600,000)   1,400,000  
Accrued expenses and other current liabilities             (2,200,000)   7,300,000   (13,100,000)  
Deferred contract revenue             5,200,000   (1,700,000)   (8,400,000)  
Other assets             500,000   200,000   500,000  
Other liabilities             7,500,000   (8,500,000)   (5,300,000)  
Increase in accounts payable             2,600,000   (2,500,000)   (2,700,000)  
Net cash provided by operating activities             53,600,000   39,500,000   14,700,000  
INVESTING ACTIVITIES:                        
Acquisitions of businesses, net of cash and cash equivalents acquired             (290,100,000)   (55,700,000)   (9,100,000)  
Purchases of property, plant, and equipment and badges             (23,200,000)   (19,900,000)   (16,500,000)  
Net cash used in investing activities             (313,300,000)   (75,600,000)   (25,600,000)  
FINANCING ACTIVITIES:                        
Borrowings from notes payable to third-parties, net of discount and issuance costs             218,800,000 $ 300,000 98,800,000   596,800,000  
Principal repayments             (14,800,000)   (13,400,000)   (560,200,000)  
Deferred finance costs                 (8,100,000)  
Borrowings from notes payable – related parties     $ 0 $ 300,000     70,000,000.0      
Borrowing on revolving term loan               80,000,000.0    
Payment on revolving term loan             (35,000,000.0)   (45,000,000.0)   (13,000,000.0)  
Payment of contingent considerations               (2,000,000.0)    
Contribution from noncontrolling interests               0   100,000  
Distributions to noncontrolling interests               (400,000)   (100,000)  
Dividends to noncontrolling interests                      
Other financing               900,000   (500,000)  
Net cash provided by financing activities             239,000,000.0   118,900,000   15,000,000.0  
Effect of exchange rate changes on cash, cash equivalents, and restricted cash             3,100,000   (400,000)   (2,400,000)  
Net (decrease) increase in cash, cash equivalents, and restricted cash             (17,600,000)   82,400,000   1,700,000  
Cash, cash equivalents, and restricted cash at beginning of year             120,000,000.0   37,600,000   35,900,000  
Cash, cash equivalents, and restricted cash at end of year $ 102,400,000 $ 120,000,000.0 102,400,000 120,000,000.0     102,400,000   120,000,000.0   $ 37,600,000  
GS Acquisition Holdings Corp II [Member]                        
OPERATING ACTIVITIES:                        
Net loss     1,013,683 (46,399) $ (295)     (45,255,407)   $ (341)   $ (295)
Adjustments to reconcile net loss to net cash provided by operating activities:                        
Change in fair value of warrant liability 968,221 0 (9,232,566) 0 0 $ 30,806,877   43,139,251   0    
Issuance costs related to warrant liability           1,075,021   1,075,021        
Changes in operating assets and liabilities:                        
Decrease in dividend receivable     125         (3,883)        
Decrease in prepaid expenses     151,670         (599,170)        
Increase in deferred tax assets     (513,624)         (265,954)        
Increase in accounts payable     7,394,888 46,399       964,734   341   295
Increase in income tax payable     0 0       57        
Net cash provided by operating activities     (1,185,824)         (945,351)        
FINANCING ACTIVITIES:                        
Principal repayments               (300,000)        
Proceeds from sale of Class B common stock to GS Sponsor II LLC                   0   5,000
Proceeds from sale of Class A common stock to public               750,000,000        
Proceeds from sale of Private Placement Warrants               17,000,000        
Payment of underwriting discounts               (15,000,000)        
Payment of offering costs     (375,000) (225,739)       (613,245)        
Proceeds From Working Capital Note     2,000,000                  
Net cash provided by financing activities     1,625,000 74,261       751,386,755       5,000
Net (decrease) increase in cash, cash equivalents, and restricted cash               750,441,404       5,000
Increase in cash and restricted cash     439,176 74,261                
Cash, cash equivalents, and restricted cash at beginning of year     750,446,404 5,000   $ 5,000 79,261 5,000   5,000    
Cash, cash equivalents, and restricted cash at end of year $ 750,885,580 $ 79,261 750,885,580 79,261 $ 5,000   $ 750,885,580 750,446,404 $ 79,261 $ 5,000   $ 5,000
Supplemental disclosure of non-cash financing activities                        
Accrued offering costs     $ 0 $ 692,952       375,000        
Deferred underwriting discount               $ 26,250,000